Artiva Biotherapeutics (ARTV) Receivables - Other (2023 - 2025)
Artiva Biotherapeutics (ARTV) has disclosed Receivables - Other for 3 consecutive years, with $67000.0 as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other fell 54.11% to $67000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $67000.0, a 54.11% decrease, with the full-year FY2025 number at $67000.0, down 54.11% from a year prior.
- Receivables - Other was $67000.0 for Q4 2025 at Artiva Biotherapeutics, down from $79000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $892000.0 in Q2 2024 to a low of $30000.0 in Q2 2025.
- A 3-year average of $288000.0 and a median of $139000.0 in 2024 define the central range for Receivables - Other.
- Biggest YoY gain for Receivables - Other was 40.15% in 2025; the steepest drop was 96.64% in 2025.
- Artiva Biotherapeutics' Receivables - Other stood at $724000.0 in 2023, then plummeted by 79.83% to $146000.0 in 2024, then crashed by 54.11% to $67000.0 in 2025.
- Per Business Quant, the three most recent readings for ARTV's Receivables - Other are $67000.0 (Q4 2025), $79000.0 (Q3 2025), and $30000.0 (Q2 2025).